It has been shown that hyperbaric oxygen (HBO) exposure may promote migration, proliferation, and differentiation of various types of adult tissue-specific stem/progenitor cells. In addition, recent studies have reported that HBO therapy significantly ameliorates the severity of central airway stenosis after lung transplantation, and also significantly reduces the exhaled nitric oxide concentration, which is an inflammatory marker of the lung and airways. To investigate the applicability of HBO on airway tissue engineering, we studied the effects of HBO exposure on both proliferation and differentiation of normal human bronchial epithelial cells derived from healthy subjects (i.e., NHBE cells) and diseased human bronchial epithelial cells derived from subjects with chronic obstructive pulmonary disease (COPD) (i.e., DHBE cells). We found that, under normoxia, DHBE cells showed significantly higher proliferation and higher expression levels of the stem/progenitor cell markers TP63 and SOX3 whereas lower expression levels of the differentiated ciliated cell marker FOXJ1 and mucous cell marker MUC5AC than NHBE cells. Consecutively and daily HBO exposure at 100% O 2 under 2.5 ATA for 40 minutes significantly increased proliferation and expression of the stem/progenitor cell markers whereas significantly decreased expression of the differentiated cell markers FOXJ1 and MUC5AC but not the neuroendocrine cell marker CGRP in NHBE cells. HBO exposure under the same condition also significantly increased proliferation whereas decreased expression of the stem/progenitor cell markers SOX2, TP63, and CC10, but not OCT4, and significantly increased expression of FOXJ1 but not MUC5AC and CGRP in DHBE cells. In addition, consecutively and daily HBO exposure significantly increased expression of both NF-κB and cleaved caspase-3 in both NHBE and DHBE cells. Taken together, our results demonstrate for the first time that HBO exposure exerts differential effects on proliferation, differentiation, and expression of stem/progenitor cell markers in NHBE and DHBE cells. Hearing loss is the fastest growing and one of the most prevalent chronic conditions today affecting 600 million people worldwide. Primary auditory neurons in the mammalian cochlea play a critical role in hearing as they transmit auditory information in the form of electrical signals from sensory hair cells in the inner ear to the cochlear nucleus in the brain. Auditory neurons do not regenerate, thus, when they are lost or damaged due to excessive noise or aging the result is permanent hearing loss. In terms of regenerative therapy, these neurons are a primary target for regeneration since the induction of even a small number of neurons in a damaged ear could have a significant impact on the amelioration of hearing impairment.
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Direct cellular reprograming of endogenous glial cells surrounding the auditory neurons holds promise for regeneration of neurons and the treatment of hearing loss. These glial cells are ideal for direct reprograming as they survive after neuron degeneration and have a partially overlapping phenotypic profile to auditory neurons such as bipolar morphology, subset of regulatory receptors, and classes of relevant voltage-gated ion channels. We used the neurogenic pioneer transcription factor Ascl1 and the auditory neuron differentiation factor NeuroD1 to reprogram glial cells into neurons.
Using the combination of Ascl1 and NeuroD1 we were able to generate induced neurons from glial cells. Overexpression of these factors in vitro induced neurons at high efficiency and these neurons Abstracts S47
